{"id":407386,"date":"2021-01-04T08:03:33","date_gmt":"2021-01-04T13:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407386"},"modified":"2021-01-04T08:03:33","modified_gmt":"2021-01-04T13:03:33","slug":"allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/","title":{"rendered":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWTON, Mass., Jan.  04, 2021  (GLOBE NEWSWIRE) &#8212; Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in two upcoming investor conferences in January:<\/p>\n<p>\n        <strong>H.C. Wainwright Bioconnect 2021 Conference<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand viewing at 6:00 a.m. ET on Monday, January 11, 2021. <\/li>\n<\/ul>\n<p>\n        <strong>15<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Stern IR Corporate Access Event<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will pre-record a corporate overview, which will become available for on-demand viewing at 7:00 a.m. ET on Monday, January 11, 2021. Management will also be available for one-on-one meetings from Monday, January 11-Thursday, January 14, 2021.<\/li>\n<\/ul>\n<p>The presentations will be available for on-demand viewing under \u201cEvents and Presentations\u201d in the Investors section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bdek67gGuiDRSva8pqOnTgThtgNDDlPdvNjdRqMRTwmZT2rr3Jj5TgD3vKdVfxgCD6gAn8OI5zlf1KboI4LI_-4pHYzscRwmcjx0Qi15Hjw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.allenapharma.com<\/a>. Replays of the webcasts will be available on the Allena website for approximately 30 days.<\/p>\n<p>\n        <strong>About Allena Pharmaceuticals<\/strong><br \/>\n        <br \/>Allena Pharmaceuticals, Inc.\u00a0is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena\u2019s lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. Allena is also developing ALLN-346 for the treatment of hyperuricemia in the setting of gout and advanced chronic kidney disease, with Phase 1b multiple-ascending dose and Phase 2 proof-of-concept studies planned for 2021.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Hannah Deresiewicz<br \/>Stern Investor Relations, Inc.<br \/>212-362-1200<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xPdTOy4OMox-rWsLaG-7UmHPsWiBD6qLdWzHzB_bH-52otxqFFx7ADT-zOsYQsDDKXlklRNJNhA13ClEbk6s1UT_O6ZQ8LI8PZRJ0AR-l5IiC-Q19m1yWU2XmwdE_FcX\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">hannah.deresiewicz@sternir.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Adam Daley<br \/>Berry &amp; Company Public Relations <br \/>212-253-8881<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CD5Op3u0bF6Q41Ah1ifU78rUJKHFuj8GYJSlGZOf2l033d1R9SaZCZ8BFC9fJSp2ivTKTOlD3ExyfrR4D9f-aaqZc9tKwppWbhKS2_uahDM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">adaley@berrypr.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/78d95e48-9380-4618-9dbd-49fa66d7b8f0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in two upcoming investor conferences in January: H.C. Wainwright Bioconnect 2021 Conference Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand viewing at 6:00 a.m. ET on Monday, January 11, 2021. 15 th Annual Stern IR Corporate Access Event Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will pre-record a corporate overview, which will become available for on-demand viewing at 7:00 a.m. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-407386","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in two upcoming investor conferences in January: H.C. Wainwright Bioconnect 2021 Conference Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand viewing at 6:00 a.m. ET on Monday, January 11, 2021. 15 th Annual Stern IR Corporate Access Event Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will pre-record a corporate overview, which will become available for on-demand viewing at 7:00 a.m. &hellip; Continue reading &quot;Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-04T13:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January\",\"datePublished\":\"2021-01-04T13:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/\",\"name\":\"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\",\"datePublished\":\"2021-01-04T13:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/","og_locale":"en_US","og_type":"article","og_title":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk","og_description":"NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) &#8212; Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that company management will participate in two upcoming investor conferences in January: H.C. Wainwright Bioconnect 2021 Conference Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand viewing at 6:00 a.m. ET on Monday, January 11, 2021. 15 th Annual Stern IR Corporate Access Event Louis Brenner, M.D., Allena\u2019s President and Chief Executive Officer, will pre-record a corporate overview, which will become available for on-demand viewing at 7:00 a.m. &hellip; Continue reading \"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-04T13:03:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January","datePublished":"2021-01-04T13:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/","name":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=","datePublished":"2021-01-04T13:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNjYyOCMzODkzNTU4IzIwOTIyNzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allena-pharmaceuticals-to-present-at-upcoming-investor-conferences-in-january\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=407386"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/407386\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=407386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=407386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=407386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}